ArticleJournal of animal science2025
Reformulation of a crystalline amino acid reference diet improves oxidation response but remains insufficient for assessing methionine bioavailability in extruded dog diets.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Previously, a semi-synthetic crystalline amino acid (AA) reference (BAS) diet, limited in methionine (Met) but providing indispensable AAs (IDAA) at 120% of Association of American Feed Control Officials (AAFCO) recommendations for adult dogs had no oxidation response, indicating another limiting AA. Thus, we could not determine the metabolic availability (MA) of dietary Met in peas and chicken meal (ChM), the latter having the lowest oxidation level. Therefore, we sought to determine if reformulating the BAS diet AA profile to match the IDAA content of the ChM diet would allow for determination of the MA of Met in peas and ChM over two experiments. In the reformulated BAS63+ diet, we increased arginine, histidine, isoleucine, leucine, lysine, threonine, and valine relative to the original BAS63- diet, while maintaining Met at 63% of requirement (0.33% DM). In Exp 1, one neutered male dog (3 years old; 30.3 kg BW) was used in a two-period switchback design to receive BAS63- and BAS63+. Following a 2-d adaptation, the indicator AA oxidation (IAAO) technique was used. The dog received 13 small meals, with meal 6 containing a priming dose (9.4 mg/kg BW) of L-[1-13C]-phenylalanine (Phe, 99%), followed by a constant dose (2.4 mg/kg BW) in meals 6-13. Breath samples were collected to measure 13CO2 enrichment, and oxidation was calculated (F13CO2/kg BW/h). The BAS63+ diet improved oxidation by 84% and was used in Exp 2. In Exp 2, seven neutered male mixed-breed dogs (3 years old; 26.3 ± 2.0 kg BW) were used in a partially replicated 5 × 5 Latin square design to receive isonitrogenous and isoenergetic dietary treatments: BAS63+, ChM63 (ChM and lamb-based diet), and PEA63 (green pea and lamb-based diet), all providing Met at 63% (0.33% DM) of requirement. Two additional BAS diets were created with Met at 19% (BAS19+; 0.10% DM) and 40% (BAS40+; 0.21% DM) of requirement. This created two and three graded levels of Met for ChM and peas, and the BAS diet, respectively, allowing for a slope ratio approach to quantify MA using the BAS19+ diet as the common first point. The IAAO technique was performed in Exp 2 using the same protocol. Data were analyzed using Proc GLIMMIX with dog and period as random effects and diet, %Met, and their interaction as fixed effects. Overall, ChM had the lowest oxidation level, and the MA of Met in peas was 58% relative to ChM. The higher oxidation in the BAS63+ compared to ChM suggests another AA may still be limiting in the BAS diet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.